Provider review
Liberty review
The price in the headline is not the price of either drug on the page.
The hero promises a plan from one figure; the product cards beneath it quote a lower one for semaglutide and a higher one for tirzepatide. Nothing on the page reconciles them, and every card is a "starting at" with no published account of what it starts from.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Liberty
$129/mo sema · $219/mo tirz, both quoted "starting at"
- Vs median
- $40/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Liberty puts both GLP-1 prices on cards a reader meets before any intake, adds free shipping, and states its coverage as a number of states rather than leaving it vague — all of which is more than a good part of this category offers. Then it prints a headline above those cards promising a plan from a figure that belongs to neither of them: it sits well above what the semaglutide card asks and below what the tirzepatide card asks, so a reader anchoring on it has the wrong expectation for whichever drug they end up on. Underneath that sits the more ordinary problem for anyone planning to stay small. Every figure is a "starting at", and the site never says what it starts from — not a starting dose, not a plan length, not a first month. A floor is only useful if you know how deep it goes, and here you cannot.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want both prices visible on the page before you begin an intake.
- You want shipping included and a stated number of served states rather than a vague claim.
- You are comparing several treatment lines from one provider — it prices its other products the same way.
Look elsewhere if
- You budget off a headline. The figure in the hero matches neither drug it sells.
- You want to know what a "starting at" price starts from. Nothing on the site says.
- You want the pharmacy named. Only a facility class is given, never a facility.
What it actually costs
Price as published
Compounded semaglutide "Starting at $129/month" and compounded tirzepatide "Starting at $219/month" on the product cards, with NAD+ at $149 and sermorelin at $116 · the hero above them reads "a licensed doctor reviews your health and prescribes the right plan — from $199/month, shipped free", and $199 is neither of those figures: it is $70 above the semaglutide card and $20 below the tirzepatide one, so it describes no product on the page · every figure is prefixed "Starting at" with nothing published about what it starts from · shipping is free from "accredited 503B pharmacies", named as a category rather than a facility · 47 states
- Vs median
- $40/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. There is no low-dose product here — one card per molecule, each quoted "starting at", so a smaller dose means asking for less inside the standard plan at the standard plan's floor. Since the site never says what the starting price starts from, a microdoser cannot tell whether holding low keeps them at that floor or whether the floor was never about dose at all.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Both GLP-1 prices sit on cards a reader meets before any intake, alongside the other treatment lines.
- Shipping is free and coverage is stated as 47 states rather than left vague.
- Fulfillment is described as 503B, which is a facility class a reader can at least look up.
Pharmacy, labs and oversight
Liberty dispenses through a Not named (described as accredited 503B pharmacies) facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What Liberty publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Liberty sells compounded semaglutide and tirzepatide alongside NAD+, sermorelin and a sexual-health line, all priced on cards a reader meets before any intake, with free shipping and coverage stated as 47 states. The problem is the number above them. Its hero promises a plan "from $199/month", and no product on the page costs $199: semaglutide starts at $129 and tirzepatide at $219. A reader who anchors on the headline overpays their expectation on one drug and underpays it on the other, and there is nothing on the page to reconcile them. Underneath that sits the more ordinary problem for anyone planning to stay on a low dose — every figure is a "starting at", and the site never says what it starts from. Not a dose, not a plan length, not a first month. So the cheapest number is a floor of unknown depth.
The honest cons
The hero advertises "from $199/month" and neither GLP-1 costs $199 — semaglutide starts at $129, tirzepatide at $219.
- Every figure is "Starting at" with nothing published about what it starts from.
- No individual pharmacy is named, only the 503B category.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Liberty is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#155 of 373
Ordered with the companies that pay us first, and Liberty is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- What a flat price costs at a low dose
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.